Stilwell Associates, L.P. 4
Accession 0001213900-25-111485
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 3:06 PM ET
Size
36.6 KB
Accession
0001213900-25-111485
Insider Transaction Report
- Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying) - Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying)
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 87,843(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 8,519(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying)
- Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying) - Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying)
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 87,843(indirect: See footnote)
Common Stock
- 8,519(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying)
- Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying) - Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying)
- 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 87,843(indirect: See footnote)
Common Stock
- 8,519(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying)
- Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying) - Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying)
- 87,843(indirect: See footnote)
Common Stock
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 8,519(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying) - Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying)
- 87,843(indirect: See footnote)
Common Stock
- 8,519(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying)
- Sale
7.00% Subordinated Convertible Notes due 2031
2025-11-13$6403672.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,147,897 underlying) - Purchase
7.00% Subordinated Convertible Notes due 2031
2025-11-13$1000000.00/sh(indirect: See footnote)Exercise: $1.74Exp: 2031-12-31→ Common Stock (179,359 underlying)
- 87,843(indirect: See footnote)
Common Stock
- 8,519(indirect: See footnote)
Common Stock
- 17,680(indirect: See footnote)
Common Stock
- 161(indirect: See footnote)
Common Stock
- (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (9,848,375 underlying) - (indirect: See footnote)
7.00% Subordinated Convertible Notes due 2031
Exercise: $1.74Exp: 2031-12-31→ Common Stock (1,437,713 underlying) - 91,278(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 13,175(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 18,158(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 1,360(indirect: See footnote)
Series D Cumulative Convertible Preferred Stock
Exercise: $85478400.00→ Common Stock (0 underlying) - 575,494(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 83,488(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying) - 130,484(indirect: See footnote)
Series B Convertible Preferred Stock
Exercise: $201600000.00→ Common Stock (0 underlying)
Footnotes (10)
- [F1]These securities are owned directly by Stilwell Activist Investments, L.P. ("SAI") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Stilwell Value LLC ("Value"), which is the general partner of SAI. Joseph Stilwell disclaims beneficial ownership of all shares reported as owned indirectly except to the extent of his pecuniary interest therein.
- [F10]Each share of Series B Preferred Stock is convertible, in whole or in part, at any time, at the option of the holders thereof, into 0.0000001 shares of the Issuer's common stock (a conversion price of $201,600,000 per share of common stock). Series B Preferred Stock has no expiration date.
- [F2]These securities are owned directly by Stilwell Activist Fund, L.P. ("SAF") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SAF. Joseph Stilwell disclaims beneficial ownership of all shares reported as owned indirectly except to the extent of his pecuniary interest therein.
- [F3]These securities are owned directly by Stilwell Value Partners VII, L.P. ("SVP VII") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SVP VII. Joseph Stilwell disclaims beneficial ownership of all shares reported as owned indirectly except to the extent of his pecuniary interest therein.
- [F4]These securities are owned directly by Stilwell Associates, L.P. ("SA") and indirectly by Joseph Stilwell in his capacity as the managing member and owner of Value, which is the general partner of SA. Joseph Stilwell disclaims beneficial ownership of all shares reported as owned indirectly except to the extent of his pecuniary interest therein.
- [F5]The Issuer's 7.00% Subordinated Convertible Notes due 2031 (the "Notes") are convertible, in whole or in part, at any time, at the option of the holders thereof, into shares of the Issuer's common stock at a conversion price of $1.742315 per share (14.348723 common shares for each $25.00 of principal amount of the Notes being converted).
- [F6]Interest on the Notes may be payable, at the Issuer's election, in cash, in shares of the Issuer's Series B Convertible Preferred Stock ("Series B Preferred Stock") or in shares of the Issuer's Series D Cumulative Convertible Preferred Stock ("Series D Preferred Stock"), in each case as set forth in the Notes.
- [F7]The price reported in Column 8 is an aggregate purchase price. These Notes were sold at a price of $80.0459 per $25.00 of aggregate principal amount.
- [F8]The price reported in Column 8 is an aggregate purchase price. These Notes were purchased at a price of $80.00 per $25.00 of aggregate principal amount.
- [F9]Each share of Series D Preferred Stock is convertible, in whole or in part, at any time, at the option of the holders thereof, into 0.0000003 shares of the Issuer's common stock (a conversion price of $85,478,400 per share of common stock). Series D Preferred Stock has no expiration date.
Documents
Issuer
Wheeler Real Estate Investment Trust, Inc.
CIK 0001527541
Related Parties
1- filerCIK 0000913960
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 3:06 PM ET
- Size
- 36.6 KB